50 μg
Anti-SARS-CoV-2 (COVID-19) Nucleocapsid Protein (NP) Polyclonal Antibody
Purified Rabbit polyclonal antibody (IgG) raised against a synthetic peptide corresponding to aa 1-100 of Nucleocapsid Protein from SARS-CoV-2 (COVID-19). It detects nucleoprotein from SARS-CoV-2 with minimal cross-reactivity to MERS-CoV.
Concentration: 1 mg/ml
Clonality: Polyclonal
Form in stock: Liquid – 1 mg/mL.
Host: Rabbit
Immunogen: Synthetic peptide targeting amino acids 1-100 of SARS-CoV-2 nucleoprotein.
Clonality: Polyclonal
Isotype: IgG
Formulation: In 0.01 M Tris-HCl, pH 8.0, 0.15 M NaCl, 0.02% sodium azide.
Purity: >95% based on SDS-PAGE
Conjugation: Unconjugated
Alternative names: COVID-19 COV-2.
Shipping: Shipped on Dry Ice.
Storage: Store at -20ºC. Product is stable for 6 weeks at 2-8 ºC as undiluted liquid. Prepare fresh dilutions for every new experiment. Avoid freeze/thaw cycles.
Regulatory/ Restrictions: For Research Use Only.
Application: Suggested Dilution
Western Blot: 0.5-2 μg/ml
Indirect ELISA (as detecting antibody): 1-2 μg/ml
Sandwich ELISA: 2 μg/ml
Immunohistochemistry: 2-10 μg/ml (not recommended without antigen retrieval)
 | Immunohistochemistry analysis of patient lung biopsy samples infected with SARS-CoV-2. A: Diagnosed with non-specific lung infection. B: using Anti-SARS-CoV-2 NP antibody (BSV-COV-AB-07). Antibody concentration used was 2-10μg/ml and HRP-conjugated Goat Anti-Rabbit IgG was used as secondary antibody. |
 | Western Blot analysis of purified recombinant Nucleoprotein from SARS-CoV-2 using Anti-SARS-CoV-2 NP antibody (BSV-COV-AB-07). Primary antibody dilution used was 0.5-2μg/ml. |